$DCTH News

Delcath Systems to Host Third Quarter 2026 Earnings Call

Delcath Systems Highlights Clinical Program Presentations at ESMO Congress 2026 and Independent Data on Percutaneous Hepatic Perfusion in Liver-Dominant Metastatic Uveal Melanoma

Delcath Systems Presents Data Regarding Its Clinical Development Programs At European Society For Medical Oncology Congress 2026; Presents Publication Of Analysis Of Percutaneous Hepatic Perfusion With Melphalan Using CHEMOSAT Hepatic Delivery Systems

Delcath Systems Q2 2026 Earnings Call Transcript

Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Delcath’s (DCTH) Liver Cancer Device Keeps Growing, But At A Cost

Delcath Systems to Participate in Upcoming Investor Conferences

What Makes Delcath Systems, Inc. (DCTH) a Strong Momentum Stock: Buy Now?

Recent Price Trend in Delcath Systems (DCTH) is Your Friend, Here's Why

Wall Street Analysts Believe Delcath Systems (DCTH) Could Rally 52.44%: Here's is How to Trade

Delcath Systems (DCTH) Is a Great Choice for 'Trend' Investors, Here's Why

Here's Why Delcath Systems, Inc. (DCTH) is a Great Momentum Stock to Buy

Does Delcath Systems (DCTH) Have the Potential to Rally 42.77% as Wall Street Analysts Expect?

Delcath: Temporary Headwinds Are Fading While Larger Opportunities Approach

HC Wainwright & Co. Maintains Buy on Delcath Systems, Raises Price Target to $32

Delcath Systems, Inc. (DCTH) Q2 2026 Earnings Call Transcript

Delcath Systems Q2 Earnings Call Highlights

BTIG Maintains Buy on Delcath Systems, Raises Price Target to $21

Delcath Systems, Inc. (DCTH) Tops Q2 Earnings and Revenue Estimates

Delcath Systems Reports Second Quarter 2026 Results and Business Highlights